Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 4.50 is 23% below its 4-year average of 5.82, around the middle of its 4-year range (0.00–7.56).
As of the fiscal period ended Tuesday, June 30, 2026. 27.18% below its 12-month average of 6.19.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.50.
QUICK RATIO (ACID-TEST)
4.50
QUICK RATIO (ACID-TEST) AVG TTM
6.19
QUICK RATIO (ACID-TEST) AVG 3Y
5.68
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-27.18%
CURRENT VS 3Y AVG
-20.74%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.17
median of 724 covered companies
CURRENT VS SECTOR MEDIAN
+41.87%
vs the sector median at left
Metagenomi, Inc. Common Stock
Market Cap
$40.28M
Quick Ratio (Acid-Test)
4.50
TTM Avg
6.19
3Y Avg
5.68
5Y Avg
N/A
Market Cap
$40.91M
Quick Ratio (Acid-Test)
2.08
TTM Avg
2.23
3Y Avg
2.23
5Y Avg
2.23
Market Cap
$38.96M
Quick Ratio (Acid-Test)
0.98
TTM Avg
0.82
3Y Avg
0.91
5Y Avg
1.06
Market Cap
$38.00M
Quick Ratio (Acid-Test)
48.81
TTM Avg
25.84
3Y Avg
15.89
5Y Avg
15.79
Market Cap
$42.97M
Quick Ratio (Acid-Test)
0.76
TTM Avg
2.59
3Y Avg
1.53
5Y Avg
1.04
Market Cap
$37.86M
Quick Ratio (Acid-Test)
2.76
TTM Avg
5.79
3Y Avg
4.84
5Y Avg
5.49
Market Cap
$36.63M
Quick Ratio (Acid-Test)
2.06
TTM Avg
1.18
3Y Avg
0.60
5Y Avg
0.79
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Metagenomi, Inc. Common Stock (MGX) | $40.28M | 4.50 | 6.19 | 5.68 | N/A |
| Nephros, Inc. (NEPH)vs › | $39.63M | 2.71 | 3.27 | 3.24 | 4.04 |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.91M | 2.08 | 2.23 | 2.23 | 2.23 |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.96M | 0.98 | 0.82 | 0.91 | 1.06 |
| Precipio, Inc. (PRPO)vs › | $41.92M | 1.56 | 1.00 | 1.05 | 1.35 |
| Incannex Healthcare Limited (IXHL)vs › | $38.00M | 48.81 | 25.84 | 15.89 | 15.79 |
| BioStem Technologies, Inc. (BSEM)vs › | $42.97M | 0.76 | 2.59 | 1.53 | 1.04 |
| Edesa Biotech, Inc. (EDSA)vs › | $37.86M | 2.76 | 5.79 | 4.84 | 5.49 |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.63M | 2.06 | 1.18 | 0.60 | 0.79 |
| CVRx, Inc. (CVRX)vs › | $44.05M | 6.87 | 8.83 | 11.21 | 12.90 |
Quick Ratio
4.50
Excludes inventory
Current Ratio
4.50
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 4.50 |
| 2026-03-31 | 6.43 |
| 2025-12-31 | 7.22 |
| 2025-09-30 | 6.42 |
| 2025-06-30 | 6.36 |
| 2025-03-31 | 5.85 |
| 2024-12-31 | 6.91 |
| 2024-09-30 | 6.18 |
| 2024-06-30 | 5.82 |
| 2024-03-31 | 4.75 |
| 2023-12-31 | 4.04 |
| 2023-09-30 | 4.36 |
| 2023-06-30 | 5.04 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 7.56 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.00 |
